Clinical Trial Update: Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver [Phase 3]

View source ↗

Summary

Phase 3 trial comparing metformin versus pioglitazone on liver enzymes and ultrasound changes in non-diabetic non-alcoholic fatty liver disease (NAFLD) complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: King Edward Medical University | Conditions: NAFLD | Phase 3 | Status: COMPLETED